Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
Conditions: Non-small Cell Lung Cancer; Leptomeningeal Disease; Central Nervous System Metastases Intervention: Drug: Afatinib Sponsor: National Cancer Centre, Singapore Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials